Annual EBIT
$9.61 B
+$661.00 M+7.39%
31 December 2023
Summary:
Bristol-Myers Squibb annual earnings before interest & taxes is currently $9.61 billion, with the most recent change of +$661.00 million (+7.39%) on 31 December 2023. During the last 3 years, it has risen by +$15.06 billion (+276.22%). BMY annual EBIT is now at all-time high.BMY EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
$2.18 B
+$374.00 M+20.70%
30 September 2024
Summary:
Bristol-Myers Squibb quarterly earnings before interest & taxes is currently $2.18 billion, with the most recent change of +$374.00 million (+20.70%) on 30 September 2024. Over the past year, it has dropped by -$236.00 million (-9.76%). BMY quarterly EBIT is now -28.68% below its all-time high of $3.06 billion, reached on 31 March 2023.BMY Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$5.11 B
-$236.00 M-4.84%
30 September 2024
Summary:
Bristol-Myers Squibb TTM earnings before interest & taxes is currently -$5.11 billion, with the most recent change of -$236.00 million (-4.84%) on 30 September 2024. Over the past year, it has dropped by -$14.88 billion (-152.34%). BMY TTM EBIT is now -151.18% below its all-time high of $9.99 billion, reached on 31 March 2023.BMY TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BMY EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +7.4% | -9.8% | -152.3% |
| 3 y3 years | +276.2% | -12.2% | -79.7% |
| 5 y5 years | +56.2% | +40.0% | -172.7% |
BMY EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +276.2% | -28.7% | +119.7% | -151.2% | at low |
| 5 y | 5 years | at high | +276.2% | -28.7% | +119.7% | -151.2% | +6.2% |
| alltime | all time | at high | +276.2% | -28.7% | +119.7% | -151.2% | +6.2% |
Bristol-Myers Squibb EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.18 B(+20.7%) | -$5.11 B(+4.8%) |
| June 2024 | - | $1.81 B(-116.3%) | -$4.88 B(+7.4%) |
| Mar 2024 | - | -$11.09 B(-657.3%) | -$4.54 B(-147.3%) |
| Dec 2023 | $9.61 B(+7.4%) | $1.99 B(-17.7%) | $9.61 B(-1.7%) |
| Sept 2023 | - | $2.42 B(+12.9%) | $9.77 B(-0.9%) |
| June 2023 | - | $2.14 B(-30.0%) | $9.86 B(-1.3%) |
| Mar 2023 | - | $3.06 B(+42.0%) | $9.99 B(+11.7%) |
| Dec 2022 | $8.95 B(-5.2%) | $2.15 B(-14.2%) | $8.95 B(-0.3%) |
| Sept 2022 | - | $2.51 B(+10.4%) | $8.97 B(+0.3%) |
| June 2022 | - | $2.27 B(+12.8%) | $8.95 B(+4.5%) |
| Mar 2022 | - | $2.01 B(-7.7%) | $8.56 B(-9.2%) |
| Dec 2021 | $9.43 B(-273.0%) | $2.18 B(-12.2%) | $9.43 B(-431.5%) |
| Sept 2021 | - | $2.48 B(+32.0%) | -$2.85 B(+4.3%) |
| June 2021 | - | $1.88 B(-34.7%) | -$2.73 B(+3.8%) |
| Mar 2021 | - | $2.88 B(-128.6%) | -$2.63 B(-51.8%) |
| Dec 2020 | -$5.45 B(-196.8%) | -$10.10 B(-487.9%) | -$5.45 B(-213.7%) |
| Sept 2020 | - | $2.60 B(+31.2%) | $4.79 B(+27.9%) |
| June 2020 | - | $1.98 B(+3320.7%) | $3.75 B(+2.3%) |
| Mar 2020 | - | $58.00 M(-61.3%) | $3.67 B(-34.9%) |
| Dec 2019 | $5.63 B(-8.5%) | $150.00 M(-90.4%) | $5.63 B(-19.9%) |
| Sept 2019 | - | $1.56 B(-18.0%) | $7.03 B(-8.5%) |
| June 2019 | - | $1.90 B(-6.2%) | $7.69 B(+21.1%) |
| Mar 2019 | - | $2.02 B(+30.3%) | $6.35 B(+3.2%) |
| Dec 2018 | $6.15 B(+15.5%) | $1.55 B(-29.8%) | $6.15 B(+15.0%) |
| Sept 2018 | - | $2.21 B(+293.4%) | $5.35 B(+22.4%) |
| June 2018 | - | $562.00 M(-69.2%) | $4.37 B(-15.2%) |
| Mar 2018 | - | $1.82 B(+143.7%) | $5.15 B(-3.3%) |
| Dec 2017 | $5.33 B(-12.4%) | $749.00 M(-39.2%) | $5.33 B(-6.6%) |
| Sept 2017 | - | $1.23 B(-8.6%) | $5.70 B(-6.1%) |
| June 2017 | - | $1.35 B(-32.6%) | $6.07 B(-4.9%) |
| Mar 2017 | - | $2.00 B(+77.6%) | $6.38 B(+5.0%) |
| Dec 2016 | $6.08 B(+169.0%) | $1.13 B(-29.7%) | $6.08 B(+32.5%) |
| Sept 2016 | - | $1.60 B(-3.4%) | $4.59 B(+14.3%) |
| June 2016 | - | $1.66 B(-2.4%) | $4.02 B(+63.3%) |
| Mar 2016 | - | $1.70 B(-562.7%) | $2.46 B(+8.8%) |
| Dec 2015 | $2.26 B(-12.5%) | -$367.00 M(-135.7%) | $2.26 B(-13.7%) |
| Sept 2015 | - | $1.03 B(+917.8%) | $2.62 B(-1.1%) |
| June 2015 | - | $101.00 M(-93.3%) | $2.65 B(-12.9%) |
| Mar 2015 | - | $1.50 B(<-9900.0%) | $3.04 B(+17.8%) |
| Dec 2014 | $2.58 B(-16.4%) | -$7.00 M(-100.7%) | $2.58 B(-26.4%) |
| Sept 2014 | - | $1.06 B(+114.2%) | $3.51 B(+5.8%) |
| June 2014 | - | $494.00 M(-52.5%) | $3.32 B(-2.5%) |
| Mar 2014 | - | $1.04 B(+12.7%) | $3.40 B(+10.2%) |
| Dec 2013 | $3.09 B(+22.5%) | $922.00 M(+6.7%) | $3.09 B(+13.1%) |
| Sept 2013 | - | $864.00 M(+49.0%) | $2.73 B(+315.8%) |
| June 2013 | - | $580.00 M(-19.9%) | $657.00 M(-44.2%) |
| Mar 2013 | - | $724.00 M(+28.4%) | $1.18 B(-53.3%) |
| Dec 2012 | $2.52 B(-64.6%) | $564.00 M(-146.6%) | $2.52 B(-29.8%) |
| Sept 2012 | - | -$1.21 B(-210.1%) | $3.59 B(-46.2%) |
| June 2012 | - | $1.10 B(-46.8%) | $6.67 B(-9.8%) |
| Mar 2012 | - | $2.07 B(+26.5%) | $7.40 B(+3.8%) |
| Dec 2011 | $7.13 B(+14.6%) | $1.64 B(-12.5%) | $7.13 B(+2.6%) |
| Sept 2011 | - | $1.87 B(+2.6%) | $6.95 B(+3.2%) |
| June 2011 | - | $1.82 B(+1.3%) | $6.73 B(+3.0%) |
| Mar 2011 | - | $1.80 B(+23.6%) | $6.53 B(+5.0%) |
| Dec 2010 | $6.22 B(+7.4%) | $1.46 B(-11.9%) | $6.22 B(+1.5%) |
| Sept 2010 | - | $1.65 B(+1.7%) | $6.12 B(+0.7%) |
| June 2010 | - | $1.62 B(+9.4%) | $6.08 B(+1.0%) |
| Mar 2010 | - | $1.49 B(+9.0%) | $6.02 B(+4.1%) |
| Dec 2009 | $5.79 B(+13.8%) | $1.36 B(-15.4%) | $5.79 B(-4.9%) |
| Sept 2009 | - | $1.61 B(+3.1%) | $6.08 B(+7.0%) |
| June 2009 | - | $1.56 B(+25.4%) | $5.69 B(+5.2%) |
| Mar 2009 | - | $1.25 B(-25.0%) | $5.41 B(-0.6%) |
| Dec 2008 | $5.09 B(+44.2%) | $1.66 B(+36.7%) | $5.44 B(+11.7%) |
| Sept 2008 | - | $1.22 B(-5.4%) | $4.87 B(+7.5%) |
| June 2008 | - | $1.28 B(+0.4%) | $4.54 B(+10.6%) |
| Mar 2008 | - | $1.28 B(+17.1%) | $4.10 B(+13.7%) |
| Dec 2007 | $3.53 B(+47.9%) | $1.09 B(+24.5%) | $3.61 B(+44.6%) |
| Sept 2007 | - | $878.00 M(+3.2%) | $2.50 B(+20.2%) |
| June 2007 | - | $851.00 M(+8.4%) | $2.08 B(-7.9%) |
| Mar 2007 | - | $785.00 M(-4231.6%) | $2.25 B(-5.5%) |
| Dec 2006 | $2.39 B(-36.2%) | -$19.00 M(-104.1%) | $2.39 B(-21.2%) |
| Sept 2006 | - | $458.00 M(-55.5%) | $3.03 B(-14.7%) |
| June 2006 | - | $1.03 B(+12.3%) | $3.55 B(-2.6%) |
| Mar 2006 | - | $917.00 M(+47.4%) | $3.64 B(-2.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2005 | $3.74 B(-16.3%) | $622.00 M(-36.5%) | $3.74 B(-9.2%) |
| Sept 2005 | - | $980.00 M(-12.8%) | $4.12 B(-4.5%) |
| June 2005 | - | $1.12 B(+11.2%) | $4.31 B(-0.5%) |
| Mar 2005 | - | $1.01 B(+1.0%) | $4.33 B(-3.0%) |
| Dec 2004 | $4.46 B(-9.5%) | $1.00 B(-14.6%) | $4.46 B(-3.4%) |
| Sept 2004 | - | $1.17 B(+2.2%) | $4.62 B(-4.6%) |
| June 2004 | - | $1.15 B(+0.3%) | $4.84 B(-2.1%) |
| Mar 2004 | - | $1.14 B(-1.1%) | $4.95 B(+0.3%) |
| Dec 2003 | $4.93 B(+20.3%) | $1.16 B(-17.1%) | $4.93 B(+10.5%) |
| Sept 2003 | - | $1.40 B(+11.4%) | $4.46 B(+7.7%) |
| June 2003 | - | $1.25 B(+10.9%) | $4.14 B(+10.7%) |
| Mar 2003 | - | $1.13 B(+64.1%) | $3.74 B(-8.7%) |
| Dec 2002 | $4.10 B(-20.5%) | $688.00 M(-36.0%) | $4.10 B(-4.6%) |
| Sept 2002 | - | $1.07 B(+26.2%) | $4.30 B(-9.2%) |
| June 2002 | - | $852.00 M(-42.7%) | $4.74 B(-11.7%) |
| Mar 2002 | - | $1.49 B(+67.7%) | $5.36 B(-2.3%) |
| Dec 2001 | $5.16 B(-13.8%) | $886.00 M(-41.4%) | $5.49 B(-11.6%) |
| Sept 2001 | - | $1.51 B(+2.4%) | $6.21 B(-0.2%) |
| June 2001 | - | $1.48 B(-8.3%) | $6.22 B(-0.4%) |
| Mar 2001 | - | $1.61 B(+0.2%) | $6.24 B(+1.3%) |
| Dec 2000 | $5.99 B(+14.3%) | $1.61 B(+5.2%) | $6.16 B(+3.7%) |
| Sept 2000 | - | $1.53 B(+1.9%) | $5.95 B(+3.2%) |
| June 2000 | - | $1.50 B(-2.0%) | $5.76 B(+3.2%) |
| Mar 2000 | - | $1.53 B(+10.2%) | $5.58 B(+1.0%) |
| Dec 1999 | $5.24 B(+17.6%) | $1.39 B(+3.5%) | $5.53 B(+15.3%) |
| Sept 1999 | - | $1.34 B(+1.8%) | $4.79 B(-0.1%) |
| June 1999 | - | $1.32 B(-10.7%) | $4.79 B(+3.3%) |
| Mar 1999 | - | $1.48 B(+125.7%) | $4.64 B(+4.1%) |
| Dec 1998 | $4.46 B(+0.4%) | $654.00 M(-51.4%) | $4.46 B(-8.7%) |
| Sept 1998 | - | $1.35 B(+15.6%) | $4.88 B(+3.2%) |
| June 1998 | - | $1.16 B(-9.9%) | $4.73 B(+2.9%) |
| Mar 1998 | - | $1.29 B(+20.0%) | $4.60 B(+3.6%) |
| Dec 1997 | $4.44 B(+12.3%) | $1.08 B(-9.9%) | $4.44 B(+3.0%) |
| Sept 1997 | - | $1.20 B(+15.9%) | $4.31 B(+3.3%) |
| June 1997 | - | $1.03 B(-8.9%) | $4.17 B(+2.7%) |
| Mar 1997 | - | $1.13 B(+19.5%) | $4.06 B(+2.8%) |
| Dec 1996 | $3.95 B(+9.3%) | $948.00 M(-10.6%) | $3.95 B(+2.2%) |
| Sept 1996 | - | $1.06 B(+14.8%) | $3.87 B(+2.7%) |
| June 1996 | - | $923.00 M(-9.7%) | $3.77 B(+1.6%) |
| Mar 1996 | - | $1.02 B(+18.4%) | $3.71 B(+2.5%) |
| Dec 1995 | $3.62 B(+12.2%) | $863.00 M(-9.9%) | $3.62 B(+3.3%) |
| Sept 1995 | - | $958.00 M(+11.1%) | $3.50 B(+2.5%) |
| June 1995 | - | $862.00 M(-7.5%) | $3.42 B(+2.7%) |
| Mar 1995 | - | $932.00 M(+24.6%) | $3.33 B(+3.2%) |
| Dec 1994 | $3.22 B(+34.0%) | $748.00 M(-14.4%) | $3.22 B(+25.3%) |
| Sept 1994 | - | $874.00 M(+13.2%) | $2.57 B(+2.0%) |
| June 1994 | - | $772.00 M(-6.8%) | $2.52 B(+2.8%) |
| Mar 1994 | - | $828.00 M(+744.9%) | $2.45 B(+2.1%) |
| Dec 1993 | $2.40 B(+22.6%) | $98.00 M(-88.1%) | $2.40 B(+18.0%) |
| Sept 1993 | - | $823.00 M(+16.9%) | $2.04 B(+0.7%) |
| June 1993 | - | $704.00 M(-9.5%) | $2.02 B(+1.8%) |
| Mar 1993 | - | $778.00 M(-390.3%) | $1.99 B(+1.4%) |
| Dec 1992 | $1.96 B(-29.1%) | -$268.00 M(-133.2%) | $1.96 B(-30.3%) |
| Sept 1992 | - | $808.00 M(+20.8%) | $2.81 B(+0.9%) |
| June 1992 | - | $669.00 M(-10.9%) | $2.79 B(-0.9%) |
| Mar 1992 | - | $751.00 M(+28.8%) | $2.81 B(+1.7%) |
| Dec 1991 | $2.77 B(+15.8%) | $583.00 M(-25.6%) | $2.77 B(+4.2%) |
| Sept 1991 | - | $784.00 M(+12.8%) | $2.65 B(+2.6%) |
| June 1991 | - | $695.00 M(-1.3%) | $2.59 B(+3.6%) |
| Mar 1991 | - | $704.00 M(+49.2%) | $2.50 B(+4.6%) |
| Dec 1990 | $2.39 B(+120.6%) | $472.00 M(-34.1%) | $2.39 B(-162.4%) |
| Sept 1990 | - | $716.00 M(+18.2%) | -$3.83 B(+72.1%) |
| June 1990 | - | $606.00 M(+1.8%) | -$2.23 B(+279.0%) |
| Mar 1990 | - | $595.00 M(-110.4%) | -$587.00 M(-154.2%) |
| Dec 1989 | $1.08 B(-38.8%) | -$5.75 B(-347.7%) | $1.08 B(-50.4%) |
| Sept 1989 | - | $2.32 B(+3.4%) | $2.19 B(+6.0%) |
| June 1989 | - | $2.24 B(-0.9%) | $2.06 B(+7.5%) |
| Mar 1989 | - | $2.27 B(-148.8%) | $1.92 B(+8.4%) |
| Dec 1988 | $1.77 B(+20.7%) | -$4.64 B(-311.5%) | $1.77 B(-20.0%) |
| Sept 1988 | - | $2.20 B(+4.5%) | $2.21 B(+16.1%) |
| June 1988 | - | $2.10 B(-0.8%) | $1.91 B(+12.5%) |
| Mar 1988 | - | $2.12 B(-150.4%) | $1.69 B(+15.5%) |
| Dec 1987 | $1.47 B | -$4.20 B(-322.4%) | $1.47 B(-74.1%) |
| Sept 1987 | - | $1.89 B(0.0%) | $5.67 B(+50.0%) |
| June 1987 | - | $1.89 B(0.0%) | $3.78 B(+100.0%) |
| Mar 1987 | - | $1.89 B | $1.89 B |
FAQ
- What is Bristol-Myers Squibb annual earnings before interest & taxes?
- What is the all time high annual EBIT for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb annual EBIT year-on-year change?
- What is Bristol-Myers Squibb quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb quarterly EBIT year-on-year change?
- What is Bristol-Myers Squibb TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb TTM EBIT year-on-year change?
What is Bristol-Myers Squibb annual earnings before interest & taxes?
The current annual EBIT of BMY is $9.61 B
What is the all time high annual EBIT for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high annual earnings before interest & taxes is $20.12 B
What is Bristol-Myers Squibb annual EBIT year-on-year change?
Over the past year, BMY annual earnings before interest & taxes has changed by +$661.00 M (+7.39%)
What is Bristol-Myers Squibb quarterly earnings before interest & taxes?
The current quarterly EBIT of BMY is $2.18 B
What is the all time high quarterly EBIT for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high quarterly earnings before interest & taxes is $3.06 B
What is Bristol-Myers Squibb quarterly EBIT year-on-year change?
Over the past year, BMY quarterly earnings before interest & taxes has changed by -$236.00 M (-9.76%)
What is Bristol-Myers Squibb TTM earnings before interest & taxes?
The current TTM EBIT of BMY is -$5.11 B
What is the all time high TTM EBIT for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high TTM earnings before interest & taxes is $9.99 B
What is Bristol-Myers Squibb TTM EBIT year-on-year change?
Over the past year, BMY TTM earnings before interest & taxes has changed by -$14.88 B (-152.34%)